SEC Form 4 · accession 0001127602-16-044098
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas F Ackerman
Other
Period of report
Feb 27, 2016
Accepted (ET)
Mar 1, 2016 · 3:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 27, 2016 | F | 1,315 | $73.70 | D | 107,432 | D | |
| Common Stock | Feb 28, 2016 | F | 523 | $73.70 | D | 106,909 | D | |
| Common Stock | Feb 29, 2016 | A | 8,380 | $0.00 | A | 115,289 | D | |
| Common Stock | Feb 29, 2016 | F | 3,943 | $73.70 | D | 111,346 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit award originally granted on February 27, 2015.